An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia
Clinical trial NCT07584057 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07584057
- Sponsor
- Yunnan Baiyao Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2030-02-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.